Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Cai

Showing results (851-860 of 908) with videos related to

Pageof 91
Sort By:
Biorxiv : the Preprint Server for Biology|July 16, 2025
L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of <i>MYC</i> expressionWen Gu, Xun Wang, Ashley Solmonson, et al.
Vaccine|June 24, 2015
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trialTing Wu, Yue-Mei Hu, Juan Li, et al.
The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.
Lancet (London, England)|March 31, 2015
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trialFeng-Cai Zhu, Li-Hua Hou, Jing-Xin Li, et al.
BMC Pregnancy and Childbirth|September 6, 2023
Effect of noninvasive embryo viability testing versus conventional IVF on the live birth rate in IVF/ICSI patients: a study protocol for a double-blind, multicenter, randomized controlled trialYan-Fei Cheng, Cui-Lian Zhang, Yun Liu, et al.
International Journal of Cancer|April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trialFeng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Nature Communications|May 16, 2022
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathwayMona Hoseini Soflaee, Rushendhiran Kesavan, Umakant Sahu, et al.
Nature Metabolism|December 1, 2020
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancerJiyeon Kim, Hyun Min Lee, Feng Cai, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
NUDT5 regulates purine metabolism and thiopurine sensitivity by interacting with PPATZheng Wu, Phong T Nguyen, Varun Sondhi, et al.
Lancet (London, England)|December 27, 2016
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Alie H Wurie, Li-Hua Hou, et al.
Pageof 91

Showing results (851-860 of 908) with videos related to

Sort By:
Pageof 91
Biorxiv : the Preprint Server for Biology|July 16, 2025
L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of <i>MYC</i> expressionWen Gu, Xun Wang, Ashley Solmonson, et al.
Vaccine|June 24, 2015
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trialTing Wu, Yue-Mei Hu, Juan Li, et al.
The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.
Lancet (London, England)|March 31, 2015
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trialFeng-Cai Zhu, Li-Hua Hou, Jing-Xin Li, et al.
BMC Pregnancy and Childbirth|September 6, 2023
Effect of noninvasive embryo viability testing versus conventional IVF on the live birth rate in IVF/ICSI patients: a study protocol for a double-blind, multicenter, randomized controlled trialYan-Fei Cheng, Cui-Lian Zhang, Yun Liu, et al.
International Journal of Cancer|April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trialFeng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Nature Communications|May 16, 2022
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathwayMona Hoseini Soflaee, Rushendhiran Kesavan, Umakant Sahu, et al.
Nature Metabolism|December 1, 2020
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancerJiyeon Kim, Hyun Min Lee, Feng Cai, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
NUDT5 regulates purine metabolism and thiopurine sensitivity by interacting with PPATZheng Wu, Phong T Nguyen, Varun Sondhi, et al.
Lancet (London, England)|December 27, 2016
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Alie H Wurie, Li-Hua Hou, et al.
Pageof 91